I did not think Akki was speculating about an impending buy-out deal for PAB. She was merely commenting that if an early stage cancer biotech has a very good pre-clinical asset (...and from what we know PAT DX-1 ticks a number of boxes in this regard as per the most recent ASX release - i.e., novel, newly discovered mechanism of action, good IP, can target multiple cancers esp solid tumours, potential to work in synergy/combined therapy with other therapies, has the ability to be conjugated to radio nucleotides or nano particles etc etc), then there are many precedents for early stage/pre-clinical buyouts by big pharma. She was also stating (not speculating) on what we know now about the pre-clinical characteristics of PAT DX-1 in a very measured and informed way.
In regard to FDA approvals - for most small cap/early stage biotechs listed on the ASX, the path to FDA approval will usually come after the takeover by a big pharma parent. In this regard she is not speculating either and just stating the normal course of events for any successful early stage/discovery focussed biotech.
Jim, I am sure you would like to see the PAB price fall to 0.004-0.006 cents again and then sell at 2c!!
Long-term PABsters be aware - the traders are very good at downramping and upramping - just have a look at the historical posts for some of the "traders" the ill-founded, inconsistencies and contradictory comments for any given stock will amaze!!
- Forums
- ASX - By Stock
- Ann: PAT-DX1 Active in Pre-clinical Cancer Models
I did not think Akki was speculating about an impending buy-out...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $9.941K | 1.420M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 51753 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1638632 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 51753 | 0.007 |
18 | 4150686 | 0.006 |
8 | 3459992 | 0.005 |
5 | 4174000 | 0.004 |
4 | 2729016 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1614982 | 7 |
0.009 | 108695 | 1 |
0.010 | 1726000 | 3 |
0.011 | 1600000 | 3 |
0.012 | 292407 | 2 |
Last trade - 14.08pm 28/06/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online